AIM ImmunoTech (AIM) Ownership - Who owns AIM ImmunoTech?

28 days until earnings call

Profile

Industry
N/A
Address
2117 SW Highway 484
Phone
+1 352 448-7797
Employees
28
Web
https://www.aimimmuno.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
21.14M
P/E Ratio
N/A
Total Cash
N/A
Projected Growth
N/A
Total Debt
3.35M
Revenue
193K
Risk (Beta)
1.19
Dividend Yield
N/A
Total Cash/Share
N/A
Total Debt/Equity
N/A
Revenue/Share
0.00 USD as % of share price

Fundamentals

AIM
Capitalization
21.1M
P/E Ratio
N/A
Risk (Beta)
1.19
Dividend Yield
N/A
Total Cash
N/A
Total Cash/Share
N/A
Total Debt
3.35M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.00%
Revenue
193K
ROE
N/A
Book Value
4.14M
P/B Ratio
5.55
Cash Flow
N/A
Earnings
-0.64
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
50K
Current Ratio
1.14
Current Revenue Per Employee
1428.57
Dividends Per Share - Security
N/A
EBITDA
-33.75M
Float
N/A
Float - Current
N/A
Gross Income Margin
80.00
Revenue To Assets
-116.00
Shares Held By Institutions
2.57M
Shares Outstanding - Current
57.1M
Total Liabilities
11.4M
Total Volume MTD
N/A
Value
N/A
Gain YTD
-8.616
View a ticker or compare two or three
AIM
Daily Signal changed days ago
Gain/Loss if shorted
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a biopharmaceutical company, which engages in the clinical development of new drug therapies based on natural immune system enhancing technologies for the treatment of viral and immune based disorders

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
2117 SW Highway 484
Phone
+1 352 448-7797
Employees
28
Web
https://www.aimimmuno.com